SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer. [PDF]
Qi T, Yang W, Liu R, Deng D, Liu X.
europepmc +1 more source
Stem Cell-Related Gene CALR as a Novel Prognostic Factor for Bladder Cancer: Implications for Immunotherapy. [PDF]
Ling Z +5 more
europepmc +1 more source
Expression of ribosomal S6 kinase 4 in bladder cancer and its correlation with clinicopathological features. [PDF]
Li Z +11 more
europepmc +1 more source
Type I-interferon β induces a strong anti-tumour response in bladder cancer cells. [PDF]
Hesse M +5 more
europepmc +1 more source
CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues. [PDF]
Zhang X +8 more
europepmc +1 more source
Multi-omics characterization identifies AHCY as a prognostic biomarker driving immunometabolic reprogramming in bladder cancer. [PDF]
Peng Q +8 more
europepmc +1 more source
Imagine the Duture: An Ex Post Facto Analysis of the 53rd BLCA Biennial Conference
openaire +2 more sources
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy. [PDF]
van Creij NCH +17 more
europepmc +1 more source
KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression. [PDF]
Huang X +7 more
europepmc +1 more source

